Surgical Stapler Goes Global: How Lexington Medical Penetrated Over 40 Countries with Its AEON Platform

In the landscape of modern minimally invasive surgery, there is a device that, while unassuming, holds life-and-death significance—the “surgical stapler.” In procedures such as lobectomy, gastrointestinal surgery, and even tumor resection, it performs precise mechanical tissue cutting and suturing, directly impacting the control of intraoperative bleeding, postoperative healing, and infection risk. It is often hailed as the “human body’s stapler.”

In the global surgical instruments sector,The stapler market exhibits typical "double-high" characteristics: High Market Capacity and High Industry Barriers. According to Frost & Sullivan data, the global market size for surgical staplers reached $8.91 billion in 2022 and is projected to further grow to $12.93 billion by 2030, with a compound annual growth rate (CAGR) of 4.4% from 2025 to 2030. Currently, this “hot” market is firmly dominated by surgical device giants such as Medtronic and Johnson & Johnson. Meanwhile, companies like Intuitive Surgical are accelerating the substitution trend through robot-assisted surgery, leaving increasingly narrow room for new entrants to survive.

Against this backdrop, Lexington Medical has quietly entered the fray. Rather than attempting to comprehensively challenge the giants’ strategies of platform-based integration or full-spectrum product coverage, it has achieved a breakthrough in the critical step of suturing and stapling through a path of “micro-innovation”: launching the intelligent electric stapler AEON,Integrating power control, suturing precision, and user experience into one, breaking the limitations of traditional staplers in terms of comfort and stability.

In April 2025, Lexington Medical secured strategic investment from Ampersand Capital Partners, a private equity firm focused on the healthcare sector (amount undisclosed). The funds will be used to support its global product development, commercial expansion, and team building. Starting with the seemingly minor details of anastomosis,Lexington Medical now exports its products to more than 40 countries and regions worldwide., emerging as a formidable game-changer in the high-end minimally invasive surgery sector.

How Lexington Medical Carved Out a Breakthrough in a Crowded Field Dominated by Giants with a Seemingly “Niche” Innovative Device. Do Its Technological Path, Product Logic, and Market Strategy Offer a Model of “Meticulous Innovation” for Chinese Companies to Emulate?

Can Basic Tools Spark a Wave of Innovation? Leon Amariglio, Founder of Lexington Medical, Gives a Resounding Yes. A seasoned medical device engineer with over 40 medical patents to his name, Amariglio has previously founded a successful company that was acquired by Boston Scientific. Through extensive interactions with surgeons, he keenly identified longstanding issues with traditional staplers, including outdated design, insecure suturing, and poor adaptability. Although these problems have long been overlooked by the industry, they represent genuine pain points in surgical practice.

This gave Amariglio the idea to “redo the stapler.” Dissatisfied with merely making minor tweaks to existing products, he was determinedFrom structural design and power systems to physician tactile feedbackUnderwent a comprehensive restructuring. In 2013, Lexington Medical was established in Massachusetts, USA, assembling a team of experienced engineers who dedicated years to the AEON project, ultimately refining its stapler products to be smarter, more stable, and more precise.

The Lexington team is composed of core members with backgrounds from Rhythmia, Boston Scientific, and MIT (Massachusetts Institute of Technology). The entire R&D team collaborates across multiple dimensions, including surgical robotics, precision engineering, and surgical experience, forming a critical foundation for Lexington’s competitive breakthrough.

Figure 1: Profiles and Introductions of Lexington Medical’s Founder and Chief Technology Officer (Source: Lexington Medical Official Website)

Lexington Medical specializes in the development of high-performance stapling systems for open and minimally invasive surgeries,Core products include AEON and AEON Powered Stapler, both share multi-specification staple cartridge modules, forming a "modular stapling platform" that meets the needs of multiple surgical procedures including gastrointestinal, hepatobiliary and pancreatic, thoracic, bariatric, and transplantation surgeries.

Figure 2: Schematic Diagram of AEON Product (Image Source: Lexington Medical Official Website)

AEON through the ingenious design of the S3 Engineering system, namely Multi-speed Gear, Superior Staple Lines, and Smooth Articulation,It addresses key pain points of current mainstream products, such as the high failure rate in stapling thick tissues, poor hemostatic efficacy, and inadequate manual control stability.

Figure 3: Multi-speed gear: enables superior suturing and excellent hemostasis in thick tissues. (Image source: Lexington Medical official website)

Figure 4: Schematic diagram of stapler lines (Source: Lexington Medical official website)

Figure 5: Smooth Articulation: Precise Stapler Positioning with a Fluid Range of Motion. (Image source: Lexington Medical official website)

Furthermore,The triple-row safety mechanism ensures uniform stapler height for improved hemostasis and reduced bleeding.; while “The “short-head anvil” patent precisely addresses the increasingly narrow minimally invasive surgical field.trend, which has gained considerable popularity among hepatobiliary, pancreatic, and bariatric surgeons in clinical practice.

Notably, AEON currently offers 32 staple cartridge specifications, covering nearly all tissue thicknesses. This extensive range is not merely a matter of broad product availability; rather, it reflects Lexington Medical’s engineering-driven understanding of intraoperative “tissue diversity,” providing surgeons with optimal tools tailored to tissues of varying thicknesses.

Figure 6: Schematic Diagram of Staple Cartridge Specifications (Source: Lexington Medical Official Website)

Compared to traditional electric staplers, which are often bulky and heavy, require charging, have a steep learning curve, and provide insufficient haptic feedback, the AEONPowered Stapler is aTypical “Lightweight Intelligence”Product of Thought—Plug-and-play, battery-free, fully electronically controlled, and retaining haptic feedback through its S3 engineering framework, its design is clearly more aligned with the actual workflow of frontline surgeons. Although specific weight data has not been disclosed, the AEON Powered Stapler features a lightweight design that significantly reduces device weight, enhancing operational convenience and comfort, making it particularly suitable for surgical scenarios involving prolonged, high-frequency use.

Furthermore, the AEONPowered Stapler demonstrates superior performance in suturing thick tissues (Figure 7).

Figure 7: Comparison of the AEONPowered Stapler with mainstream products in thick tissue stapling (Image source: Lexington Medical official website)

In multiple clinical trials, the AEON series demonstrated performance benchmarked against leading products such as Echelon Flex and ENDO GIA, showcasingHemostasis Control, Tissue Adaptability, Suture Consistency(Figures 8 and 9) Leading advantages in dimensions such as^[1], the significance of relevant clinical study data lies not only in “statistical significance,” but also indicates that its product strategy and engineering architecture are gradually gaining recognition among physicians.

Figure 8: In ex vivo porcine model testing, the AEON series demonstrated superior suture formation compared to mainstream products (Image source: Lexington Medical official website)

Figure 9: The AEON series products have higher tensile strength than mainstream products (Source: Lexington Medical official website)

EspeciallyAchieving “Zero Staple Line Bleeding” in Thoracic Surgery PracticePresentation of^[2], which not only reflects its engineering quality but also signifies that Lexington Medical is gradually breaking through the market barriers built by strong brands and channel advantages, carving out a niche in the highly stable surgical stapler sector.

The Advantages of the AEON Stapler: Beyond Parameter Upgrades to Consistent Surgeon-Recognized Intraoperative ExperienceThe advantages of the AEON stapler lie not only in its upgraded specifications but also in the highly consistent recognition of its “intraoperative experience” by surgeons. Across global multicenter use, physicians have widely reported smooth firing and adequate compression, particularly demonstrating more reliable anastomotic quality and a lower risk of complications when handling thick tissues (such as the stomach, pancreas, and lungs).

In the global surgical stapler market, traditional giants such as Johnson & Johnson and Medtronic have long held dominant positions. Confronted with a landscape characterized by high barriers to entry, resource-intensive operations, and strong brand loyalty, Lexington Medical has pursued a strategy of focused specialization: targeting critical intraoperative details to build differentiated product capabilities, leveraging its global partnership network to accelerate international expansion, and gradually establishing platform-based competencies.

Lexington prioritized surgeons’ actual needs during the early product definition phase, translating feedback on issues such as “uneven stapling pressure,” “poor tissue adaptability,” and “device bulk obstructing the surgical field” into engineering parameters. This approach led to the development of the AEON series of staplers, which emphasize comfortable handling, structural stability, and precise stapling.

Among them,The Company’s Pioneering Short-Head Anvil Structure Has Been Filed for or Granted Multiple PatentsBy shortening the length of the stapler’s distal end and optimizing the contact angle between the anvil and tissue, this design effectively expands the intraoperative field of view, enhances stapling stability, and improves adaptability to varying tissue thicknesses, thereby reducing tissue trauma caused by stapler bluntness. This subtle modification reflects a profound understanding of intraoperative details and establishes a technical moat for the AEON product characterized by “micro-innovation and strong practicality,” serving as a key technological foundation for its international expansion.

In 2022,Lexington Medical Enters into Global Commercial Partnership with BOWA Medical, Germany’s Leading Energy Surgery Company. The two parties have bundled the AEON stapler with BOWA’s LOTUS ultrasonic energy device, creating synergistic expansion across multiple markets in Europe, Asia, and other regions.

The LOTUS system is a vascular sealing device that employs torsional ultrasonic technology, enabling precise control of energy output during dissection and hemostasis. Its patented design significantly reduces collateral thermal injury, making it suitable for operations near high-risk tissues. When combined with the superior hemostatic performance of the AEON system, the two create a closed-loop “energy + stapling” solution in surgical scenarios such as gastrointestinal, hepatobiliary-pancreatic, and bariatric procedures, thereby enhancing overall surgical efficiency.

This collaboration also marks a significant step for Lexington Medical in its transition from a single-product stapler manufacturer to a provider of “comprehensive intraoperative solutions.” Although Lexington Medical currently remains focused on its standalone stapler product line, it is gradually forming the prototype of a surgical ecosystem integrating “stapling systems + energy platforms + global sales networks,” driven by technological evolution, portfolio expansion, and business model transformation. This lays a solid foundation for its global expansion.

Lexington’s path to success demonstrates that even in a highly competitive sector, focusing on key intraoperative procedural steps can"Building Clinical Empathy", truly understanding every subtle need and pain point in the operating room can break traditional patterns and achieve technological breakthroughs. This concept is gradually transforming from an inspiration into a practical reference for innovative enterprises in China’s medical device sector.

In recent years, a growing number of Chinese enterprises have been striving to move beyond the path of “catch-up incremental improvement,” shifting instead toward original designs driven by engineering system optimization and intraoperative clinical needs. For instance, Richu Surgical has launched its independently developed electric stapler system, which offers differentiated advantages characterized as “three innovations and one ease”: new blades, new angulation, new intelligence, and ease of operation. Fenghe Medical continues to invest heavily in high-end minimally invasive medical consumables and robotics projects, demonstrating its capability for system-level engineering integration.

In terms of international expansion, Chinese medical device companies are accelerating their breakthroughs beyond regional boundaries, achieving a strategic transformation from "Made in China" to "global brands." Taking Intuitive Surgical (Yitukang) as an example, its independently developed surgical instruments have successfully entered over 40 core healthcare markets in Europe and the United States since entering the international market in 2021, with product competitiveness gaining international recognition. Tianchen Medical has continued to refine its global marketing network by deepening its strategic partnership with B. Braun Melsungen AG, with its business now covering 62 countries and regions.

In the future, those who can provide lighter and smarter surgical tools amidst the growing trend toward increasingly refined and complex minimally invasive surgeries will have the opportunity to build globally competitive, original Chinese medical device brands.

Amid the wave of surgical instruments becoming “intelligent” and “robotic,” Lexington has chosen to start with a surgical stapler, refining this “basic tool” to perfection and demonstrating an almost artisan-like steadfastness in innovation.

It demonstrates using the AEON stapler:Hard Innovation in Healthcare: No Need to Be UnconventionalBy directly addressing the most pressing clinical pain points in surgical procedures, even a simple “stapler” can revitalize the vitality of medical devices in the new era.

References:

1. Redmann, James G et al. “Improving Hemostasis in Sleeve Gastrectomy With Alternative Stapler.” JSLS : Journal of the Society of Laparoendoscopic Surgeons vol. 24,4 (2020): e2020.00073. doi:10.4293/JSLS.2020.00073

2. A. Dutly, K. Katona, A. Has, J. Grups, and P.J. Leskow. Use of a New Stapling Device in General Thoracic Surgery [abstract]. Am J Respir Crit Care Med 2022;205:A3346.